Saeid Babaei

BriaCell Therapeutics Corp.

Image: Saeid Babaei

Saeid Babaei, Ph.D., chairman of BriaCell, holds executive positions in multiple biotech companies. He is CEO of AbCelex, which recently obtained investment from a top agtech/biotech venture capitalist and was vice president of Lorus Therapeutics, where he was responsible for a large turnaround and the out-licensing of a Phase 3 cancer immuno-oncology program to a private equity firm. He was director of corporate development at Northern Therapeutics, which was successfully partnered to United Therapeutics.



Due to permission requirements, not all quotes are shown.